REFERENCES
- Viracept® (nelfinavir mesylate). [Product information]. La Jolla, CA: Agouron Pharmaceuticals, Inc; 2001.
- Pun E, Daniels E, Petersen C, Mota J. Nelfinavir-associated diarrhea: incidence, time course and treatment. In: Pro-gram and abstracts of the 1st IAS Conference on HIV Pathogenesis and Treatment; July 8–11, 2001; Buenos Aires, Argentina. Abstract #119.
- Andrade A, Sears C, Rufo P, Lencer W, Flexner C. Charac-terization of nelfinavir (NFV)-associated diarrhea: secretory versus osmotic. In: Program and abstracts of the 7th Con-ference on Retroviruses and Opportunistic Infections; January 30 — February 2, 2000; San Francisco, California. Abstract 62.
- Flexner C. HIV-protease inhibitors. N Engl J Med. 1998;338:1281–1292.
- Jensen-Fangel S, Justesen US, Black FT, Pederson C, Obel N. The use of calcium carbonate in nelfinavir-associ-ated diarrheoea in HIV-1-infected patients. HIV Med. 2003;4:48–52.
- Perez-Rodriguez E, Gonzalez L, Kopp B. The role of calcium supplementation in the treatment of nelfinavir-in-duced diarrhea. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Che-motherapy; September 26–29, 1999; San Francisco, Cali-fornia. Abstract 1307.
- Razzeca K, Odenheimer S, Davis M, Landeck K. The treat-ment of nelfinavir induced diarrhea. In: Program and ab-stracts of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland. Abstract 12383.
- Zoli G, Care M, Spano R, Bernardi R, Gasbarrini G. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease. Gastroenterology. 1995;106:A766.
- Klimberg VS, Salloum RM, Kasper M, et al. Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg. 1990;125:1040–1045.
- Rhoades JM, Keku EO, Quinn J, Woosley J, Ceece JG. L-glutamine stimulates jejunal sodium and chloride absorp-tion in pig rotavirus enteritis. Gastroenterology. 1991;100:683–691.
- Heiser CR, French N, Gordon PR, et al. Dietary supplemen-tation with probiotics, soluble fiber and L-glutamine re-duces diarrhea in HIV+ men receiving nelfinavir. In: Pro-gram and abstracts of the 1st IAS Conference on HIV Pathogenesis and Treatment; July 8–11, 2001; Buenos Aires, Argentina. Abstract 904.
- Calder PC. Glutamine and the immune system. Clin Nutr. 1994;13:2–8.
- Caldwell MD. Local glutamine metabolism in wounds and inflammation. Metabolism. 1989;38(suppl):S34–539.
- Kew S, Wells SM, Yacloob P, Wallace FA, Miles EA, Calder PC. Dietary glutamine enhances murine T-lymphocytes responsiveness. J Nutr. 1997;129:1524–1531.
- Lacey JM, Wilmore DW. Is glutamine a conditionally essen-tial amino acid? Nutr Rev. 1990;48:297–309.
- Newsholmes EA, Parry-Billings M. Properties of glutamine release from the muscle and its importance for the immune system. JPEN. 1990;14:635–675.
- Smith R. Glutamine metabolism and its physiologic impor-tance. JPEN. 1990;14:405–435.
- Wilmore DW, Shabert JK. Role of glutamine in immuno-logic responses. Nutrition. 1998;14:618.
- Ogle CK, Ogle JD, Mao JX. Effect of glutamine on phago-cytosis and bacterial killing by normal and pediatric burn patient neutrophils. JPEN. 1994;18:28–133.
- Fahr MJ, Kornbluth J, Blossom S, Schaeffer R, Klimberg VS. Glutamine enhances immunoregulation of tumor growth. JPEN. 1994;18:471–476.
- Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444–447.
- Lands L. NAC, glutamine and alpha lipoic acid. AIDS Treat-ment News. 1997; 268:1–8.
- Smigelski C. Eat Up - Nutrition Advice and Food Ideas for People with HIV. Boston MA: Harvard University Press, 1996:38.
- Panigrahi P, Gewolb IH, Bamford P, Horvath K. Role of glutamine in bacterial transcytosis and epithelial cell injury. JPEN. 1997;21(2):75–80.
- Tso P, Crissinger K. Overview of digestion and absorption. In: Biochemical and Physiological Aspects of Human Nutri-tion. Philadelphia, PA: WB Saunders; 2000:79.
- Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS HIV). Qual Life Res. 1997;6:481–493.